Cognizant (NASDAQ: CTSH), a leading provider of information technology, consulting, and business process services, today announced a presentation at the following investor conference: J.P. Morgan...

TOLMAR Pharmaceuticals, Inc. announced today that clinical data from four pivotal trials demonstrate that ELIGARD® (leuprolide acetate for injectable suspension) maintains stable, long-term...

Two new studies evaluating the impact of cycling on the sexual health and urinary functions of men and women will be presented at a special press conference during the 112th Annual Meeting of the...

Opioid misuse and the dangers of using certain medications in the elderly are growing health concerns in the United States, as a growing body of knowledge demonstrates a potential need for...

Two sexually transmitted diseases – Zika virus and human papilloma virus (HPV) – are the focus of two new studies, which demonstrate that new techniques to test and prevent these viruses can...

Four studies examining female pelvic and sexual health, show promising results for women with hypoactive sexual desire disorder (HSDD), an association between low testosterone levels and...

A new study being presented at the 112th Annual Scientific Meeting of the American Urological Association (AUA) shows topical 4% benzocaine wipes improved the physical and psychological symptoms...

A series of studies evaluating the relationship between shift work, sleep disorders and a man's urologic health will be presented at a special press conference during the 112th Annual Meeting of...

Data being presented at the 112th Annual Scientific Meeting of the American Urological Association (AUA) shows new facts related to the impact of certain genetic mutations on the risk and...

Genomic Health, Inc. (Nasdaq: GHDX) today announced results from two Oncotype DX® Genomic Prostate Score™ (GPS) test analyses based on a prospective, multi-center, 1,200-patient study. Results...